EF
Econ Financial Services Corp
13F filer · CIK 0001659718Reported Jul 23, 2026
Net seller this quarter
13F portfolio value$214MU.S. long equity reported on 13F
Positions4121 new · 25 closed
Net flow last quarter-$11.6MBuys minus sells
Top 10 positions weight21.5%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 23, 202641 positions | |||||
| $6.13M | 2.87% | 0.02% | +75.2% | Q4 2018 | |
| PBPMBSPuramed Bioscience Inc. | $6.05M | 2.83% | 0.06% | +23.3% | Q4 2025 |
| $5.11M | 2.39% | 0.00% | -33.6% | Q1 2022 | |
| $4.88M | 2.28% | 0.00% | +58.3% | Q4 2025 | |
| $4.47M | 2.09% | 0.00% | +25.6% | Q1 2022 | |
| $4.24M | 1.98% | 0.01% | Not reported | Q2 2024 | |
| $4.07M | 1.90% | 0.00% | +13.8% | Q3 2024 | |
| $3.97M | 1.86% | 0.01% | Not reported | Q1 2023 | |
| $3.69M | 1.73% | 0.01% | Not reported | Q2 2023 | |
| $3.48M | 1.62% | 0.00% | Not reported | Q4 2018 | |
| $3.39M | 1.58% | 0.00% | +2.5% | Q4 2024 | |
| $3.31M | 1.55% | Not reported | +3.7% | Q2 2024 | |
| $3.25M | 1.52% | 0.00% | Not reported | Q2 2023 | |
| $3.13M | 1.46% | 0.03% | New | Q2 2026 | |
| $3.11M | 1.45% | 0.00% | +112.3% | Q1 2022 | |
| $2.85M | 1.33% | 0.00% | +45.7% | Q4 2024 | |
| $2.76M | 1.29% | 0.01% | Not reported | Q2 2024 | |
| $2.74M | 1.28% | 0.01% | Not reported | Q2 2025 | |
| $2.62M | 1.23% | 0.00% | Not reported | Q1 2022 | |
| $2.44M | 1.14% | 0.00% | +33.3% | Q2 2019 | |
| $2.26M | 1.06% | 0.00% | New | Q2 2026 | |
| $2.17M | 1.01% | 0.00% | Not reported | Q1 2022 | |
| $2.09M | 0.98% | 0.01% | New | Q2 2026 | |
| $2.06M | 0.96% | 0.01% | +86.9% | Q1 2022 | |
| $1.99M | 0.93% | 0.02% | New | Q2 2026 | |
| $1.94M | 0.91% | 0.00% | Not reported | Q4 2024 | |
| $1.82M | 0.85% | 0.03% | +48.7% | Q1 2022 | |
| $1.77M | 0.82% | 0.02% | Not reported | Q1 2022 | |
| $1.36M | 0.64% | 0.00% | +43.3% | Q4 2025 | |
| $1.06M | 0.49% | 0.01% | New | Q2 2026 | |
| $967K | 0.45% | 0.02% | New | Q2 2026 | |
| LPLEGLeggett & Platt Inc | $756K | 0.35% | 0.05% | New | Q2 2026 |
| $749K | 0.35% | 0.00% | New | Q2 2026 | |
| $736K | 0.34% | 0.02% | New | Q2 2026 | |
| $701K | 0.33% | 0.00% | +0.2% | Q2 2019 | |
| $588K | 0.27% | 0.00% | New | Q2 2026 | |
| $429K | 0.20% | 0.00% | -93.3% | Q4 2018 | |
| $381K | 0.18% | 0.00% | +0.1% | Q4 2018 | |
| $340K | 0.16% | Not reported | +1.0% | Q1 2023 | |
| $269K | 0.13% | Not reported | -12.3% | Q4 2018 | |
| $224K | 0.10% | 0.00% | +1.1% | Q1 2022 | |
| Q1 2026Reported Apr 21, 202645 positions | |||||
| $6.73M | 3.12% | 0.00% | +753.7% | Q1 2022 | |
| $4.96M | 2.30% | 0.00% | +50.5% | Q1 2023 | |
| PBPMBSPuramed Bioscience Inc. | $4.93M | 2.29% | 0.05% | +77.7% | Q4 2025 |
| $4.72M | 2.19% | 0.00% | +26.2% | Q4 2018 | |
| $4.57M | 2.12% | 0.01% | +49.4% | Q4 2018 | |
| $4.32M | 2.01% | 0.00% | +4.8% | Q1 2025 | |
| $4.15M | 1.93% | 0.01% | -7.0% | Q4 2018 | |
| $4.15M | 1.93% | 0.00% | +477.4% | Q1 2022 | |
| $3.95M | 1.83% | 0.00% | +52.7% | Q3 2025 | |
| $3.81M | 1.77% | 0.01% | New | Q1 2026 | |
| $3.55M | 1.65% | 0.00% | +2.7% | Q1 2022 | |
| $3.34M | 1.55% | 0.09% | +57.1% | Q1 2023 | |
| $3.16M | 1.47% | 0.00% | +26.8% | Q3 2024 | |
| $3.12M | 1.45% | Not reported | Not reported | Q1 2023 | |
| $3.02M | 1.40% | 0.00% | +28.7% | Q4 2024 | |
| $2.84M | 1.32% | 0.00% | +40.4% | Q4 2025 | |
| $2.81M | 1.31% | Not reported | Not reported | Q2 2024 | |
| $2.73M | 1.27% | 0.01% | New | Q1 2026 | |
| $2.55M | 1.18% | 0.02% | New | Q1 2026 | |
| $2.42M | 1.12% | 0.01% | +0.4% | Q4 2024 | |
| $1.95M | 0.91% | 0.00% | -48.3% | Q4 2024 | |
| $1.95M | 0.91% | 0.02% | -24.3% | Q4 2024 | |
| $1.92M | 0.89% | 0.00% | New | Q1 2026 | |
| $1.78M | 0.83% | 0.00% | New | Q1 2026 | |
| $1.68M | 0.78% | 0.01% | -62.3% | Q1 2022 | |
| $1.55M | 0.72% | 0.00% | New | Q1 2026 | |
| $1.53M | 0.71% | 0.00% | Not reported | Q1 2022 | |
| $1.52M | 0.70% | 0.00% | Not reported | Q2 2019 | |
| $1.5M | 0.70% | 0.00% | -20.4% | Q1 2019 | |
| $1.48M | 0.69% | 0.04% | Not reported | Q3 2022 | |
| $1.45M | 0.67% | 0.00% | New | Q1 2026 | |
| $1.42M | 0.66% | 0.00% | -52.3% | Q1 2022 | |
| $1.34M | 0.62% | 0.00% | Not reported | Q1 2022 | |
| $1.29M | 0.60% | 0.03% | New | Q1 2026 | |
| $1.22M | 0.57% | 0.02% | Not reported | Q1 2022 | |
| $981K | 0.46% | 0.00% | +56.2% | Q2 2025 | |
| $894K | 0.42% | 0.04% | New | Q1 2026 | |
| $885K | 0.41% | 0.09% | New | Q1 2026 | |
| $806K | 0.37% | 0.00% | +11.4% | Q4 2025 | |
| $703K | 0.33% | 0.17% | New | Q1 2026 | |
| $656K | 0.30% | 0.00% | +0.3% | Q2 2019 | |
| $367K | 0.17% | 0.00% | +1.1% | Q4 2018 | |
| $334K | 0.16% | Not reported | Not reported | Q1 2023 | |
| $321K | 0.15% | Not reported | -10.3% | Q4 2018 | |
| $212K | 0.10% | 0.00% | +1.2% | Q1 2022 | |
| Q4 2025Reported Jan 15, 202647 positions | |||||
| $5.11M | 2.56% | 0.00% | +547.7% | Q1 2022 | |
| $4.29M | 2.15% | 0.00% | +234.2% | Q4 2024 | |
| $4.17M | 2.09% | 0.00% | +26.3% | Q1 2022 | |
| $4.06M | 2.03% | 0.00% | Not reported | Q1 2025 | |
| $4.05M | 2.03% | 0.00% | +101.7% | Q4 2018 | |
| $3.96M | 1.99% | 0.02% | New | Q4 2025 | |
| $3.91M | 1.96% | 0.01% | +3.7% | Q4 2018 | |
| $3.82M | 1.91% | 0.00% | Not reported | Q4 2018 | |
| $3.66M | 1.83% | 0.00% | +14.6% | Q1 2023 | |
| $3.4M | 1.71% | 0.01% | +82.5% | Q1 2022 | |
| $3.19M | 1.60% | 0.01% | +9.0% | Q4 2018 | |
| $3.18M | 1.60% | 0.00% | +23.5% | Q1 2022 | |
| $3.02M | 1.51% | 0.00% | +24.1% | Q3 2024 | |
| $2.93M | 1.47% | 0.01% | +2.7% | Q1 2019 | |
| $2.86M | 1.43% | 0.00% | +6.8% | Q3 2025 | |
| PBPMBSPuramed Bioscience Inc. | $2.78M | 1.39% | 0.03% | New | Q4 2025 |
| $2.78M | 1.39% | 0.00% | +24.3% | Q1 2022 | |
| $2.71M | 1.36% | 0.00% | Not reported | Q1 2022 | |
| $2.5M | 1.26% | 0.02% | -24.8% | Q1 2022 | |
| $2.5M | 1.25% | 0.03% | +39.9% | Q3 2023 | |
| $2.37M | 1.19% | 0.00% | -34.7% | Q4 2024 | |
| $2.34M | 1.17% | 0.01% | Not reported | Q4 2024 | |
| $2.33M | 1.17% | 0.00% | New | Q4 2025 | |
| $2.21M | 1.11% | 0.00% | New | Q4 2025 | |
| $2.13M | 1.07% | 0.00% | New | Q4 2025 | |
| $2.02M | 1.01% | 0.06% | Not reported | Q1 2023 | |
| $1.97M | 0.99% | 0.01% | New | Q4 2025 | |
| $1.94M | 0.97% | 0.00% | Not reported | Q1 2019 | |
| $1.88M | 0.94% | 0.00% | -18.8% | Q2 2025 | |
| $1.88M | 0.94% | 0.01% | New | Q4 2025 | |
| $1.84M | 0.92% | 0.01% | New | Q4 2025 | |
| $1.8M | 0.90% | 0.02% | Not reported | Q4 2024 | |
| $1.63M | 0.82% | 0.00% | -36.1% | Q3 2025 | |
| $1.46M | 0.73% | 0.03% | New | Q4 2025 | |
| $1.4M | 0.70% | 0.00% | -23.5% | Q3 2025 | |
| $1.17M | 0.59% | 0.00% | New | Q4 2025 | |
| $971K | 0.49% | 0.02% | New | Q4 2025 | |
| $873K | 0.44% | 0.00% | Not reported | Q1 2022 | |
| $776K | 0.39% | 0.01% | Not reported | Q4 2024 | |
| $707K | 0.35% | 0.00% | New | Q4 2025 | |
| $694K | 0.35% | 0.00% | New | Q4 2025 | |
| $637K | 0.32% | 0.00% | Not reported | Q1 2022 | |
| $626K | 0.31% | 0.00% | Not reported | Q2 2025 | |
| $592K | 0.30% | 0.00% | -0.8% | Q2 2019 | |
| $408K | 0.20% | Not reported | Not reported | Q4 2018 | |
| $307K | 0.15% | 0.00% | -87.5% | Q4 2018 | |
| $204K | 0.10% | 0.00% | +1.1% | Q1 2022 | |
| Q3 2025Reported Oct 21, 202545 positions | |||||
| $3.87M | 1.93% | 0.01% | +16.1% | Q4 2018 | |
| $3.68M | 1.84% | 0.00% | +32.0% | Q1 2019 | |
| $3.61M | 1.80% | 0.00% | +4.8% | Q1 2022 | |
| EAEAElectronic Arts Inc. | $3.28M | 1.64% | Not reported | +42.5% | Q2 2025 |
| $3.26M | 1.63% | 0.02% | +123.8% | Q1 2022 | |
| $3.16M | 1.58% | 0.00% | +34.0% | Q1 2023 | |
| $3.06M | 1.52% | 0.01% | +118.5% | Q4 2024 | |
| $2.78M | 1.39% | 0.00% | +43.0% | Q1 2022 | |
| $2.56M | 1.28% | 0.01% | +41.4% | Q1 2019 | |
| $2.54M | 1.27% | 0.00% | New | Q3 2025 | |
| $2.52M | 1.26% | 0.00% | New | Q3 2025 | |
| $2.48M | 1.24% | 0.00% | New | Q3 2025 | |
| $2.41M | 1.20% | 0.00% | -40.5% | Q3 2024 | |
| $2.4M | 1.19% | 0.01% | +5.2% | Q4 2018 | |
| $2.33M | 1.16% | Not reported | Not reported | Q2 2024 | |
| $2.2M | 1.10% | 0.00% | -25.5% | Q4 2018 | |
| $2.13M | 1.06% | 0.00% | +43.1% | Q1 2022 | |
| $2.12M | 1.05% | 0.00% | +139.4% | Q2 2025 | |
| $2.03M | 1.01% | 0.00% | New | Q3 2025 | |
| $2M | 1.00% | Not reported | +41.1% | Q3 2022 | |
| $1.97M | 0.98% | 0.03% | +186.3% | Q1 2025 | |
| $1.95M | 0.97% | 0.00% | Not reported | Q4 2018 | |
| $1.93M | 0.96% | 0.00% | Not reported | Q1 2022 | |
| $1.92M | 0.96% | 0.00% | +63.3% | Q1 2022 | |
| $1.85M | 0.92% | 0.02% | Not reported | Q3 2023 | |
| $1.82M | 0.91% | 0.00% | +46.4% | Q1 2022 | |
| $1.78M | 0.89% | 0.01% | Not reported | Q1 2022 | |
| $1.56M | 0.78% | 0.00% | New | Q3 2025 | |
| $1.54M | 0.77% | 0.00% | Not reported | Q4 2024 | |
| $1.41M | 0.70% | 0.00% | New | Q3 2025 | |
| $1.21M | 0.60% | 0.00% | New | Q3 2025 | |
| $1.07M | 0.54% | 0.00% | New | Q3 2025 | |
| $1.05M | 0.53% | 0.01% | New | Q3 2025 | |
| $854K | 0.43% | 0.01% | New | Q3 2025 | |
| $831K | 0.41% | 0.00% | -53.9% | Q1 2022 | |
| $800K | 0.40% | 0.00% | Not reported | Q1 2022 | |
| $739K | 0.37% | 0.00% | Not reported | Q1 2022 | |
| $688K | 0.34% | 0.00% | Not reported | Q1 2023 | |
| $682K | 0.34% | 0.01% | New | Q3 2025 | |
| $652K | 0.32% | Not reported | New | Q3 2025 | |
| $578K | 0.29% | 0.00% | +0.3% | Q2 2019 | |
| $453K | 0.23% | Not reported | Not reported | Q4 2018 | |
| $332K | 0.17% | 0.00% | +0.9% | Q1 2022 | |
| $237K | 0.12% | 0.00% | Not reported | Q1 2022 | |
| $213K | 0.11% | 0.00% | Not reported | Q1 2022 | |
Premium opens every quarter this fund has filed